HXB Intrinsic Valuation and Fundamental Analysis - AIM ImmunoTech Inc

A	AIM ImmunoTech Inc XMUN:HXB	US
S	Sun Life Financial Inc XMUN:LIE	CA
C	Canadian Natural Resources Ltd DUS:CRC	CA
	Continental AG SIX:CON	DE

Intrinsic Value

Is HXB undervalued or overvalued?

See the intrinsic value estimate for AIM ImmunoTech Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

HXB Intrinsic Value

Unlock

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price €0.12

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What AIM ImmunoTech Does

Biotechnology Health Care

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. The company is headquartered in Ocala, Florida and currently employs 19 full-time employees. The firm is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19.

Headquarters: United States of America US
Employees: 20
IPO date: Jul 12, 1996